Keytruda 100 mg (Pembrolizumab) – Advanced Immunotherapy for Cancer Treatment

What Is Keytruda?

Keytruda (generic name: pembrolizumab) is a monoclonal antibody that belongs to the class of PD‑1 immune checkpoint inhibitors. It is supplied as a 100 mg/4 mL vial (25 mg/mL) for intravenous infusion. Keytruda is FDA‑ and EMA‑approved for treating over 20 different cancer types, making it one of the most widely used immunotherapies worldwide.

How Keytruda Works

Cancer cells often evade detection by exploiting the PD‑1 pathway, which suppresses immune responses. Keytruda works by:

• Blocking PD‑1 receptors on T‑cells.
• Reactivating immune cells to recognize and destroy cancer cells.
• Enhancing long‑term immune surveillance, reducing recurrence risk.

This mechanism makes Keytruda a cornerstone of modern immunotherapy.

Dosage & Administration

• Formulation: Injectable solution, 100 mg/4 mL vial.
• Administration: Intravenous infusion over 30 minutes.
• Typical dosing:
  • 200 mg every 3 weeks, or
  • 400 mg every 6 weeks.
• Treatment duration: Until disease progression, unacceptable toxicity, or up to 24 months in patients without progression.

Approved Indications

Keytruda is approved for a wide range of cancers:

• Melanoma – unresectable or metastatic, and adjuvant therapy after surgery.
• Non‑Small Cell Lung Cancer (NSCLC) – first‑line or adjuvant therapy, alone or with chemotherapy.
• Head & Neck Squamous Cell Carcinoma (HNSCC) – recurrent or metastatic cases.
• Urothelial Carcinoma (Bladder Cancer) – locally advanced or metastatic.
• Colorectal Cancer – MSI‑H or dMMR tumors.
• Gastric & Esophageal Cancer – PD‑L1 positive advanced cases.
• Cervical Cancer, Hodgkin Lymphoma, Renal Cell Carcinoma, Endometrial Carcinoma, Triple‑Negative Breast Cancer, and more.

Benefits of Keytruda

• Broad efficacy: Effective across multiple tumor types.
• Durable responses: Many patients experience long‑term remission.
• Combination potential: Can be used with chemotherapy, targeted therapy, or radiation.
• Global recognition: Approved by FDA, EMA, and other regulatory bodies worldwide.

Safety & Precautions

Like all immunotherapies, Keytruda carries risks:

• Common side effects: Fatigue, rash, diarrhea, nausea, decreased appetite.
• Serious risks: Immune‑mediated adverse reactions such as pneumonitis, colitis, hepatitis, endocrinopathies, and nephritis.
• Monitoring: Patients require regular blood tests and clinical evaluations to detect immune‑related complications early.

Global Availability

Prime Equine Meds ensures secure and reliable access to Keytruda 100 mg across multiple regions:

• UK & Ireland – Fast tracked delivery with pharmacy‑approved sourcing.
• Canada & USA – Licensed distribution with compliance to local regulations.
• Australia & New Zealand – Safe import channels for oncology use.
• Europe (Germany, France, Spain, Portugal, Switzerland, etc.) – Multilingual support and EU‑compliant supply chain.

Why Choose Prime Equine Meds?

• Authenticity Guaranteed: Genuine pembrolizumab sourced from trusted manufacturers.
• Worldwide Shipping: Covering major European countries, UK, Canada, and Australia.
• Expert Support: Guidance on safe handling, storage, and administration.
• Customer Confidence: Transparent policies, secure checkout, and responsive service

Keytruda 100 mg is the trade name for the drug Pembrolizumab. It is injected into a vein through an IV. Keytruda is a prescription oncology medicine that is given by a health care professional.

Keytruda 100 mg

is the trade name for the drug Pembrolizumab. It is injected into a vein through an IV. Keytruda is a prescription oncology medicine that is given by a health care professional.

Keytruda 100 mg Injection Uses:

Keytruda (Pembrolizumab) is used for the treatment of :

• unresectable or metastatic melanoma.
  • metastatic non-small cell lung cancer (NSCLC).
  • patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
  • adult and pediatric patients with refractory classical Hodgkin lymphoma (cHL), or those who have relapsed after three or more prior lines of therapy.
  • primary mediastinal large B-cell lymphoma (PMBCL).
  • certain types of stomach cancer and
  • a certain type of cervical cancer.

Keytruda Pembrolizumab 100 mg Injection Work?

In the body, there is a type of white blood cell that watches out for signs of infection or disease and can also assault cancer cells. These white blood cells are called T cells. On the surface of these T cells are certain proteins known as programmed cell death receptors (PD-1). So that T cells don’t destroy healthy cells, they use these surface proteins, or PD-1, to bind to and communicate with PD-L1 and PD-L2, proteins that permit cells to escape attack from the body’s immune system.

In other words, when the PD-1 protein on T cells comes in contact with PD-L1 and PD-L2 proteins, they are given the signal to allow that cell to live and spread. By blocking PD-1, Pembrolizumab increases the ability of your immune system to attack melanoma cells and tumors. This cancer medicine can release T cells so that it can penetrate melanoma anywhere in your body.

Keytruda 100 mg Injection Side – Effects:

This medicine may cause some serious, life-threatening side-effects. This does not mean that everyone who takes it will experience them. It depends on the medicine and how your body reacts. The following are some of the side effects that are known to be associated with this medicine :

Common Side Effects : Cough ; Joint pain ; Feeling tired ; Loss of appetite ; Mild diarrhea or constipation ; Difficulty falling asleep or staying asleep ; Changes in skin color etc.

Serious Side Effects : Chest pain or shortness of breath ; New or worsening cough ; Pale skin ; Easy bruising or bleeding ; Severe stomach pain ; Bloody or cloudy urine ; Swelling in the ankles or feet ; Rapid heartbeats ; Increased hunger or thirst ; Hoarseness ; Weight gain or weight loss ; Hair loss etc.

These are not all the possible side effects of Pembrolizumab 100mg Injection. If you notice any other side-effects, contact your doctor or pharmacist for further advice.

Keytruda 100 mg Injection – Storage Details :

Many factors can damage your medication, including heat, air, light, and moisture. It’s important to keep in mind that where you store your medication can affect its potency and safety. Following storage instructions will be helpful in storing the drug in the best of manner. Keytruda 100 mg Keytruda 100 mg Keytruda 100 mg

• Store Pembrolizumab Injection in between 2°C to 8°C.
  • Store in original carton in refrigerator (35 to 46 degrees F) until time of use
  • Keep this anti-cancer drug in a safe place so that children & pets can not reach it.
  • Keep your medicines separate from your spouse or other family members. This will make it less likely that you take the wrong ones by mistake. Keytruda 100 mg Keytruda 100 mg Keytruda 100 mg
  • Discard Keytruda if it contains particulate matter, is cloudy, or discolored.

Keytruda 100 mg (pembrolizumab) is a groundbreaking immunotherapy that has transformed cancer treatment worldwide. By harnessing the immune system, it offers hope and improved survival for patients across multiple cancer types. Prime Equine Meds is committed to providing safe, authentic, and accessible Keytruda to patients globally, ensuring they receive the care they deserve.